In vivo, knockout of CCL2 in primary tumors of mice injected intradermally with B16-F10 (melanoma) and LLC cells (lung carcinoma) inhibited this neutrophil activation in tumor-bearing mice, and CCL2 knockout tumors showed earlier metastasis in vivo. Here, CCL2 is linked to melanoma.